Placebo matched to atacicept
Sponsors
EMD Serono, Merck KGaA, Darmstadt, Germany
Conditions
Optic NeuritisRelapsing Multiple SclerosisRheumatoid Arthritis
Phase 2
A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)
CompletedNCT00430495
Start: 2006-12-31End: 2009-09-30Updated: 2016-02-17
Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)
CompletedNCT00595413
Start: 2007-09-30End: 2009-10-31Updated: 2016-02-17
Atacicept in Subjects With Optic Neuritis
TerminatedNCT00624468
Start: 2008-06-30End: 2011-01-31Updated: 2016-02-17
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
TerminatedNCT00642902
Start: 2008-04-30End: 2009-09-30Updated: 2016-05-24
Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)
CompletedNCT00664521
Start: 2008-03-31End: 2010-10-31Updated: 2016-12-30